RG 7256

Drug Profile

RG 7256

Alternative Names: PLX-3603; RG7256; RO-5212054

Latest Information Update: 20 Mar 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Plexxikon
  • Developer Plexxikon; Roche
  • Class Antineoplastics; Pyridines; Pyrroles; Small molecules; Sulfonamides
  • Mechanism of Action Proto oncogene protein b raf inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Colorectal cancer; Malignant melanoma; Solid tumours

Most Recent Events

  • 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Australia (PO)
  • 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Denmark (PO)
  • 16 Oct 2012 Discontinued - Phase-I for Colorectal cancer in Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top